AKBA- Akebia Therapeutics, Inc.

Name: Akebia Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Akebia Therapeutics, Inc. (AKBA) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. AKBA is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Butler John P.	3.46M	$4.02M	-
CFO	Ostrowski Erik	320.0K	$371.2K	-
Dir	Smith Cynthia	160.9K	$186.7K	-
Dir	Frieson Ron	129.5K	$150.2K	-
VP	Malabre Richard C	119.0K	$138.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 1, 2021	Hadas Nicole R.60	SVP, Chief Legal Officer	Sell	1,060	$3.40	$3,604.00	-0.4%	+13.8%	-79.9%
Apr 1, 2021	Dahan Michel59	SVP, Chief Operating Officer	Sell	1,211	$3.40	$4,117.40	-0.5%	+13.8%	-79.9%
Apr 1, 2021	Butler John P.61	CEO And President	Sell	4,109	$3.40	$13,970.60	-0.4%	+13.8%	-79.9%
Apr 1, 2021	Burke Steven Keith61	SVP, Chief Medical Officer	Sell	1,081	$3.40	$3,675.40	-0.6%	+13.8%	-79.9%
Mar 1, 2021	Butler John P.61	CEO And President	Sell	49,990	$3.40	$169,771.04	-2.2%	+1.3%	-36.1%
Mar 1, 2021	Faulkingham Dell70	CCO	Sell	6,749	$3.40	$22,920.28	-5.0%	+1.3%	-36.1%
Mar 1, 2021	Hadas Nicole R.60	SVP, Chief Legal Officer	Sell	14,285	$3.40	$48,513.29	-2.6%	+1.3%	-36.1%
Mar 1, 2021	Dahan Michel59	SVP, Chief Operating Officer	Sell	14,547	$3.40	$49,403.07	-2.7%	+1.3%	-36.1%
Mar 1, 2021	Burke Steven Keith61	SVP, Chief Medical Officer	Sell	7,558	$3.40	$25,667.72	-4.5%	+1.3%	-36.1%
Jun 8, 2020	Gowen Maxine	Director	Sell	4,567	$12.05	$55,032.35	-15.9%	-	-

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC